Loading...

Categories

23 Inhibitors Reports

Plasma Protease C1-inhibitor Market

Study Period: 2019 - 2029

Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America

Major Players: CSL Behring LLC, Takeda Pharmaceutical Company Limited (Shire Pharmaceutical Holdings), Pharming Technologies B.V., KalVista Pharmaceuticals, Inc., BioCryst Pharmaceuticals

Enzyme Inhibitors Market

Study Period: 2019 - 2029

Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America

Major Players: Abbott Laboratories, AstraZeneca PLC, Bayer Ag, Boehringer Ingelheim International GmbH, Amgen Inc.

Global Interleukin Inhibitors Market

Study Period: 2019 - 2029

Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America

Major Players: AbbVie, Inc, Johnson and Johnson, Novartis AG, Eli Lilly and Company, GlaxoSmithKline Plc

Tyrosine Kinase Inhibitors Market

Study Period: 2019 - 2029

Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America

Major Players: Boehringer Ingelheim International, F. Hoffmann-La Roche, AstraZeneca plc, Novartis AG, Bayer AG

Proton Pump Inhibitors Industry

Study Period: 2021 - 2029

Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America

Major Players: Bayer AG, Pfizer Inc., Takeda Pharmaceuticals, Cadila Pharmaceuticals, AstraZeneca

Asia Pacific DPP Drugs Market

Study Period: 2018 - 2029

Countries Covered: Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, Thailand, Vietnam

Major Players: AstraZeneca, Eli Lilly and Company, Merck and Co., Novartis AG, Bristol-Myers Squibb

Europe Alpha-Glucosidase Inhibitors Industry

Study Period: 2018 - 2029

Countries Covered: Germany, Spain, Italy, France, United Kingdom, Russia

Major Players: Takeda, Pfizer, Bayer, Sun Pharma, Glenmark

Latin America Alpha-Glucosidase Inhibitors Industry

Study Period: 2019 - 2029

Countries Covered: Brazil, Mexico

Major Players: Takeda, Pfizer, Bayer, Sun Pharma, Glenmark

Middle East And Africa Alpha-Glucosidase Inhibitors Industry

Study Period: 2018 - 2029

Countries Covered: South Africa, Saudi Arabia, Oman, Egypt, Iran

Major Players: Takeda, Pfizer, Bayer, SunPharma, Glenmark

Asia-Pacific Alpha-Glucosidase Inhibitors Industry

Study Period: 2018 - 2029

Countries Covered: Japan, China, South Korea, India, Australia, Malaysia, Indonesia, Philippines, Thailand

Major Players: Takeda, Pfizer, Bayer, Sun Pharma, Glenmark

Alpha Glucosidase Inhibitor Drugs Market

Study Period: 2018 - 2029

Regions Covered: North America, Europe, Latin America, Asia Pacific, Middle East and Africa

Major Players: Sun Pharma, Bayer, Takeda, Torrent Pharmaceuticals, Pfizer Inc.

PD1 and PDL1 Inhibitors Industry

Study Period: 2019 - 2029

Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America

Major Players: Bristol-Myers Squibb Company, Merck & Co., F. Hoffmann-La Roche AG, Pfizer Inc., GSK plc

Immune Checkpoint Inhibitor Market

Study Period: 2019 - 2029

Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America

Major Players: Bristol Myers Squibb Company, Regeneron Pharmaceuticals Inc, AstraZeneca plc, F. Hoffmann-La Roche AG, Merck & Co Inc

Esomeprazole Market

Study Period: 2021 - 2029

Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America

Major Players: Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Viatris Inc., DAIICHI SANKYO COMPANY, LIMITED, Sun Pharmaceutical Industries Ltd.

MEA Sodium-dependent Glucose Co-transporter 2 Inhibitors Market

Study Period: 2019 - 2029

Countries Covered: Saudi Arabia, Iran, Egypt, Oman, South Africa

Major Players: Astrazeneca, Bristol-Myers Squibb, Eli Lilly, Janssen, Astellas

Latin America Sodium-Glucose Cotransport-2 Inhibitor Industry

Study Period: 2019 - 2029

Countries Covered: Brazil, Mexico

Major Players: Astrazeneca, Eli Lilly, Astellas, Bristol Myers Squibb, Janssen

DDP4 Inhibitors Industry in Europe

Study Period: 2018 - 2029

Countries Covered: France, Germany, Italy, Spain, United Kingdom, Russia

Major Players: AstraZeneca, Takeda, Novartis, Merck & Co., Inc., Eli Lilly and Company

North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market

Study Period: 2021- 2029

Countries Covered: United States, Canada

Major Players: Merck, AstraZeneca, Eli lilly, Boehringer Ingelheim Pharmaceuticals Inc., Novartis

Latin America DPP-4 Inhibitors Industry

Study Period: 2019 - 2029

Countries Covered: Mexico, Brazil

Major Players: AstraZeneca, Novartis, Boehringer Ingelheim, Merck and Co., Eli Lilly and Company

DPP4 Drugs Industry

Study Period: 2018 - 2029

Regions Covered: North America, Europe, Latin America, Asia Pacific, Middle East and Africa

Major Players: Merck, AstraZeneca, Boehringer Ingelheim Pharmaceuticals Inc., Pfizer Inc., Eli Lilly and Company

North America Alpha-Glucosidase Inhibitors Industry

Study Period: 2019- 2029

Major Players: Takeda, Pfizer, Bayer, Sunpharma, Glenmark

Imatinib Drug Market

Study Period: 2019 - 2029

Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America

Major Players: Sun Pharmaceutical Industries Ltd, Novartis AG, Teva Pharmaceutical Industries Ltd, Mylan N.V, Dr. Reddy's Laboratories

TNF Inhibitors Market

Study Period: 2021 - 2029

Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America

Major Players: UCB Inc, Pfizer Inc, Johnson & Johnson, Amgen Inc., Abbvie

Filter Reports

By Region

By Countries